Effectiveness of the 2023 Southern Hemisphere Influenza Vaccine Against Outpatient Influenza-Like Illness: A Multi-Country Test-Negative Design Study - Top-Institutions - MDSpire

Effectiveness of the 2023 Southern Hemisphere Influenza Vaccine Against Outpatient Influenza-Like Illness: A Multi-Country Test-Negative Design Study

  • By

  • Annette K Regan

  • Radhika Gharpure

  • Monique Chilver

  • Nigel Stocks

  • Siobhan St George

  • Sibongile Walaza

  • Anne von Gottberg

  • Nicole Wolter

  • Cheryl Cohen

  • Aaron M Samuels

  • Kriengkrai Prasert

  • Prabda Praphasiri

  • William W Davis

  • Chakrarat Pittayawonganon

  • Sheena G Sullivan

  • Eduardo Azziz-Baumgartner

  • September 17, 2025

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Centers for Disease Control and Prevention (CDC)
    Centers for Disease Control and Prevention (CDC)

    Atlanta, GA

    Key Differentiators

    • Infectious Diseases
    • Epidemiology
    • Vaccine Effectiveness

  • #2

    World Health Organization (WHO) Collaborating Centre for Reference and Research on Influenza, Melbourne
    World Health Organization (WHO) Collaborating Centre for Reference and Research on Influenza, Melbourne

    Melbourne, Victoria

    Key Differentiators

    • Virology
    • Influenza Surveillance
    • Vaccine Research

  • #3

    National Institute for Communicable Diseases (NICD)
    National Institute for Communicable Diseases (NICD)

    Johannesburg, Gauteng

    Key Differentiators

    • Infectious Diseases
    • Epidemiology
    • Public Health Surveillance

  • #4

    Thai National Institute of Health (NIH)
    Thai National Institute of Health (NIH)

    Nonthaburi, Thailand

    Key Differentiators

    • Infectious Diseases
    • Vaccine Effectiveness
    • Public Health Surveillance

Original Source(s)

Effectiveness of the 2023 Southern Hemisphere Influenza Vaccine Against Outpatient Influenza-Like Illness: A Multi-Country Test-Negative Design Study

  • by Annette K Regan, Radhika Gharpure, Monique Chilver, Nigel Stocks, Siobhan St George, Sibongile Walaza, Anne von Gottberg, Nicole Wolter, Cheryl Cohen, Aaron M Samuels, Kriengkrai Prasert, Prabda Praphasiri, William W Davis, Chakrarat Pittayawonganon, Sheena G Sullivan, Eduardo Azziz-Baumgartner

  • September 17, 2025

Related Content

Stewardship Cuts Steroid Prescribing

Behaviorally informed peer comparison feedback was associated with a gradual decline in glucocorticoid prescribing

Ensitrelvir Reduced COVID After Household Exposure

In SCORPIO-PEP, symptomatic COVID-19 occurred in 3% vs 9% of household contacts by day 10.

Editorial: Lipid influence on lung immune-structural cell crosstalk: implications for respiratory health